New hope for tough lupus: scientists test 'Living Drug' made from donated cord blood
NCT ID NCT07274059
Summary
This early-stage study is testing a new type of treatment called CAR-T cell therapy for adults with severe lupus that hasn't improved with standard medications. The therapy involves collecting immune cells from donated umbilical cord blood, modifying them in a lab to target lupus, and infusing them back into the patient. The main goals are to find a safe dose and see if this approach can help control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SLE - SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The General Hospital of Western Theater Command
NOT_YET_RECRUITINGChengdu, Sichuan, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Yancheng Third People's Hospital
RECRUITINGYancheng, Jiangsu, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.